Technology Valuation Course

AUTM Annual Meeting

Technology Valuation Course

Sunday, February 20
7:30 a.m. – 4 p.m.
Camp, Third Floor

Sponsored By: 

AUTM’s Technology Valuation Course teaches the fundamental principles of how to construct the various financial terms that go into a license. The course examines concepts such as valuation versus pricing and risk, as well as a series of valuation methodologies, including cost, income, industry standards (comparables), rules of thumb, discounted cash flow and equity. The first segment concludes with a review of payment structures within a license and shows the financial flows under a typical academic-stage life sciences license.

The course goes on to focus on practical applications including case studies. The class is divided into groups to develop license term proposals for the discussion of two technologies.

If you have, or will have, responsibility for negotiating licenses, or would like to learn more about the process, the Licensing Valuation Course is ideal. Attendees should have a basic familiarity with the structure and payment mechanisms used in a license and be proficient in web searching and Excel spreadsheets.

As a prerequisite to the course, attendees will have access to the Technology Valuation Four-Part webinar series, a $325 value, and be expected to watch these videos before the start of the course.

Sunday, February 20

7:30 - 7:35 a.m. Welcome and Introductions
7:35 – 7:50 a.m. Creating Value
7:50 – 9:05 a.m. Measuring Value
9:05 – 9:20 a.m. Sharing Value
9:20 – 9:35 a.m. Break
9:35 – 10:15 a.m. Sharing Value (continued)
10:15 – 11:05 a.m. Startups
11:05 – 11:45 a.m. Case Study Discussions
11:45 a.m. – 12:45 p.m. Lunch
12:45 – 3 p.m. Case Study Discussions (continued)
3 – 3:15 p.m. Break
3:15 – 3:50 p.m. Case Study Discussions (continued)
3:50 – 4 p.m. Wrap-up and Q&A
4 p.m. Course Concludes


Annual Meeting Sponsors

NIIMBL
Parker Highlander PLLC
PhRMA
Merck
Amster, Rothstein & Ebenstein LLP
KPPB
LifeArc
Michael Best & Friedrich
Osage University Partners
Wellspring
Blank Rome LLP
Novartis
Casimir Jones, SC
Computer Packages, Inc.
LockeLord
MPEG LA LLC
Royalty Pharma
Schwegman Lundberg & Woessner
Quarles & Brady LLP
Boehringer Ingelheim Pharmaceuticals Inc.
Marshall Gerstein
Baker Donelson
Cayuse
Thomas Horstemeyer LLP
RWS
DocuSign
Berggren
DRI Capital
InfoEd
Redpath Consulting Group
KISSPlatform Europe BV
Hogan Lovells
Irell & Manella
Licensing Executives Society
Hodgson_Russ
Goldberg_Segalla
NYU Langone